Oncogenic Role of an Epigenetic Reader of m6A RNA Modification: YTHDF1 in Merkel Cell Carcinoma

Elias Orouji1,2,3, Wiebke K Peitsch2,4, Azadeh Orouji2

  • 1Skin Cancer Unit, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Cancers
|January 18, 2020
PubMed

Insights

Merkel cell carcinoma (MCC) is linked to the Merkel cell polyomavirus (MCPyV). YTHDF1, involved in RNA modifications, is amplified in MCC and may drive tumor growth by affecting viral gene expression and cell proliferation.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Merkel cell carcinoma (MCC) is an aggressive skin cancer often caused by the Merkel cell polyomavirus (MCPyV).
  • The viral small T antigen is a key oncoprotein in MCC development.
  • Understanding the molecular mechanisms driving MCC is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate genetic alterations and gene expression patterns in MCC.
  • To identify novel oncogenic drivers and their role in MCPyV-driven tumorigenesis.
  • To explore the function of YTHDF1, an m6A reader, in MCC development.

Main Methods:

  • Genomic screening for copy number aberrations and transcriptomic analysis.
  • Analysis of YTHDF1 expression and its correlation with MCPyV oncoprotein.
  • In vitro knockdown experiments in MCC cell lines to assess YTHDF1 function.
  • Correlation of YTHDF1 expression with patient survival data.

Main Results:

  • YTHDF1 exhibits high copy gains and expression in MCC.
  • YTHDF1 interacts with m6A modification on MCPyV small T antigen mRNA.
  • YTHDF1 knockdown reduces MCC cell proliferation and clonogenic capacity.
  • High YTHDF1 expression correlates with worse patient survival in MCC.

Conclusions:

  • YTHDF1 plays a significant oncogenic role in MCC tumorigenesis.
  • The YTHDF1-m6A pathway is a potential therapeutic target for MCC.
  • YTHDF1 amplification contributes to MCPyV-driven cancer development.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K